High-Resolution Map of Pancreatic Cell DNA Methylation Ties ONECUT2 to Type 2 Diabetes
The results point to epigenetic editing as a possible way to restore insulin release in worn-down beta cells.
Overview
- The Nature Metabolism study, published Friday, delivers the first cell-specific DNA methylation atlas for human pancreatic alpha and beta cells.
- Analyzing hundreds of thousands of cells from 24 donors, the team found more than 22,000 regions across nearly 8,000 genes that differ between the two hormone-producing cell types.
- CRISPR epigenetic editing in cultured beta cells altered methylation near insulin and glucagon genes to pinpoint DNA regions that control hormone production.
- Beta cells from people with type 2 diabetes showed epigenetic upregulation of the transcription factor ONECUT2, which hindered cellular energy production and cut insulin release.
- The authors launched a web tool for researchers and say next tests will probe whether methylation edits can be reversed and sustained in living systems.